Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 2529 entries
View as:

A Trial to Evaluate the Pharmacokinetics of ABL001 in Healthy and Hepatic Impaired Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02857868 Org: User:
Start: 05/03/16 End: 07/20/17 Due: 07/20/18

A Phase II, Open Label, Multiple Arm Study of AUY922, BYL719, INC280, LDK378 and MEK162 in Chinese Patients With Advanced Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02276027 Org: User:
Start: 01/20/15 End: 10/15/19 Due: 10/15/20

Study Evaluating Kesimpta® Treatment Effects in Patients With Relapsing Multiple Sclerosis Transitioning From Other Therapies

Phase: N/A Priority: Normal
NCT ID: NCT05566756 Org: User:
Start: 10/28/22 End: 04/30/25 Due: 04/30/26

A Study to Evaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple Sclerosis

Phase: N/A Priority: Normal
NCT ID: NCT01433250 Org: User:
Start: 02/29/12 End: 06/30/14 Due: 06/30/15

Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients

Phase: N/A Priority: Normal
NCT ID: NCT01431638 Org: User:
Start: 08/25/11 End: 05/09/13 Due: 05/09/14

Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00108108 Org: User:
Start: 04/30/05 End: 06/30/08 Due: 06/30/09

8-week Randomized, Open-label Study to Evaluate Food Effect on Efficacy and Safety of Oral Aliskiren 300 mg in Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01570686 Org: User:
Start: 04/30/12 End: 11/30/12 Due: 11/30/13

Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB

Phase: N/A Priority: Normal
NCT ID: NCT00805675 Org: User:
Start: 11/30/08 End: - Due: -

Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00351884 Org: User:
Start: 05/31/06 End: - Due: -

A Study to Evaluate the Effects of Indacaterol Maleate (QAB149) as a New Formulation in the EPIC Test Fixture

Phase: N/A Priority: Normal
NCT ID: NCT01845623 Org: User:
Start: 08/31/13 End: 12/31/13 Due: 12/31/14

CAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI)

Phase: N/A Priority: Normal
NCT ID: NCT05349201 Org: User:
Start: 12/09/20 End: 05/28/21 Due: 05/28/22

Safety, Pharmacokinetics and Efficacy Study of QCC374 in PAH Patients

Phase: N/A Priority: Normal
NCT ID: NCT02927366 Org: User:
Start: 09/19/17 End: 06/07/18 Due: 06/07/19

A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT05562466 Org: User:
Start: 05/11/23 End: 05/30/28 Due: 05/30/29

Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies

Phase: N/A Priority: Normal
NCT ID: NCT00670592 Org: User:
Start: 03/31/08 End: 02/28/13 Due: 02/28/14

Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE)

Phase: N/A Priority: Normal
NCT ID: NCT05203419 Org: User:
Start: 03/15/22 End: 06/04/23 Due: 06/04/24

Safety of TKI258 in Advanced/Metastatic Melanoma Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00303251 Org: User:
Start: 04/30/06 End: - Due: -

Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor

Phase: N/A Priority: Normal
NCT ID: NCT01324492 Org: User:
Start: 12/31/10 End: 06/30/14 Due: 06/30/15

Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND)

Phase: N/A Priority: Normal
NCT ID: NCT01665144 Org: User:
Start: 12/20/12 End: 03/31/23 Due: 03/31/24

A Study of Letrozole in the Treatment of Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00333086 Org: User:
Start: 01/31/00 End: - Due: -

Post-Marketing Clinical Study of Postoperative Adjuvant Therapy With Imatinib Mesylate in Patients With Gastrointestinal Stromal Tumors (GIST)

Phase: N/A Priority: Normal
NCT ID: NCT00171977 Org: User:
Start: 07/31/04 End: - Due: -

Evaluation of Number of Patient Eyes That Remained on or Switched to Anti-VEGF Treatment After Initiation of Broluciumab

Phase: N/A Priority: Normal
NCT ID: NCT05037396 Org: User:
Start: 03/05/20 End: 08/01/20 Due: 08/01/21

Efficacy and Safety of LFG316 in Transplant Associated Microangiopathy (TAM) Patients

Phase: N/A Priority: Normal
NCT ID: NCT02763644 Org: User:
Start: 04/22/16 End: 06/30/17 Due: 06/30/18

Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.

Phase: N/A Priority: Normal
NCT ID: NCT02555683 Org: User:
Start: 12/11/15 End: 11/04/19 Due: 11/04/20

Study to Evaluate Efficacy and Safety of Inclisiran in Adolescents With Heterozygous Familial Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT04652726 Org: User:
Start: 01/27/21 End: 11/27/24 Due: 11/27/25

Study of Secukinumab With 2 mL Pre-filled Syringes

Phase: N/A Priority: Normal
NCT ID: NCT02748863 Org: User:
Start: 12/12/16 End: 06/08/18 Due: 06/08/19